Basic Information
Amytrx is a clinical-stage biopharmaceutical company dedicated to developing next-generation novel anti-inflammatory peptide therapies for patients with chronic inflammatory diseases.
Amytrx Therapeutics, Inc.
Nashville,Tennessee,United States of America
less than 15 people
January 01, 2014
contact@amytrx.com